FDA has issued an Emergency Use Authorization (EUA) for convalescent plasma to be used in hospitalized COVID-19 patients, and is being investigated for the treatment of COVID-19, because there is no approved treatment for this disease. The approach has been used on an experimental basis for more than a century to fight other virulent diseases, including the 1918 flu, measles, Ebola, SARS and H1N1 influenza.
A panel of experts convened by the National Institutes of Health (NIH) countered the FDA’s decision, saying that the therapy “should not be considered the standard of care for the treatment of patients with COVID-19” and that well-designed trials are needed to determine whether the therapy is helpful.
Individuals must have complete resolution of symptoms for at least 14 days prior to donation. A negative lab test for active COVID-19 disease is not necessary to qualify for donation.
Those who have recovered from COVID-19 may have immune-boosting antibodies in their plasma. Have you tested positive for COVID-19, but are healthy? You can donate plasma.
- A prior laboratory diagnosis of COVID-19, either by a positive nasal/oral swab test OR a positive test for SARS-CoV-2 antibodies requested by your health care provider
- Complete resolution of symptoms for at least 14-28 days
- Meet all other donor eligibility for an plasma donation
Blood donors are not tested for Covid-19. Do not donate blood if you are sick.
To learn more and find the site nearest you:
- AABBExternal Link Disclaimer
- America’s Blood CentersExternal Link Disclaimer
- American Red CrossExternal Link Disclaimer
- Blood Centers of AmericaExternal Link Disclaimer
- CoVIg-19 Plasma Alliance
- National COVID-19 Convalescent Plasma Project
- Plasma Protein Therapeutics Association
- The Fight Is In Us
Together, we can save lives.